Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Multiomics-guided ex vivo drug sensitivity testing in Relapsed/Refractory Acute Myeloid Leukemia

Jeff Justin Aguilar, Vikramjit Dhillon, Sikander Chohan, Dakshin Padmanabhan, Sushmitha Nanja Reddy, Asmita Shukla, Nagasai Yalavarthi, Anisha Rajavel, Sonubar Virk, Breanna Williams, Julie Boerner, Yang Shi, Jay Yang, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 3496.

https://doi.org/10.1182/blood-2025-3496

Published: 2025

Journal Articles

Targeting the compass complex to overcome resistance in KMT2A-rearranged Acute Myeloid Leukemia

Sandhya Dhiman, Vikramjit Dhillon, Jeff Justin Aguilar, Julie Boerner, Yang Shi, Jay Yang, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 1517.

https://doi.org/10.1182/blood-2025-1517

Published: 2025

Journal Articles

Clinical implications of epigenetic age acceleration as a novel biomarker in Acute Myeloid Leukemia

Vikramjit Dhillon, Jeff Justin Aguilar, Valeria Visconte, Zachary Brady, Julie Boerner, Yang Shi, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 5290.

https://doi.org/10.1182/blood-2025-5290

Published: 2025

Journal Articles

Clonal Evolution of TP53 Configurations with Treatment Predict Prognosis in Myeloid Neoplasms

Dakshin Padmanabhan, Jeff Aguilar, Paul Kim, Sandhya Dhiman, Asmita Shukla, Vikram Dhillon, Sushmitha Nanja Reddy, David Carr, Jay Yang, Julie Boerner, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 1540.

https://doi.org/10.1182/blood-2024-210037

Published: 2024

Journal Articles

Racial Disparities in Clonal Hematopoiesis Among Solid Cancer Patients with Cardiovascular Diseases

Jeff Justin Aguilar, Vikram Dhillon, Sandhya Dhiman, Breanna Williams, Sonubar Virk, Gregory Dyson, Julie Boerner, Hadeel Assad, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 5636.

https://doi.org/10.1182/blood-2024-204416

Published: 2024

Journal Articles

Trial in Progress: Iberdomide and Daratumumab As Maintenance Therapy after an Autologous Stem Cell Transplant for Multiple Myeloma (the IBEX Trial)

Andrew Kin, Jeffrey A. Zonder, Craig Emmitt Cole, Abhinav Deol, Suresh Kumar Balasubramanian, Seongho Kim, Christiane A. Houde, Joseph Ellul, Amy Blake, Katelyn Staub, Amanda Guido, Erik Carr, Sarah Phillips, Julie Boerner

Blood (2024) 144 (Supplement 1): 7007.

https://doi.org/10.1182/blood-2024-210562

Published: 2024

Journal Articles

Longitudinal Sequencing to Investigate Clonal Evolution in Myeloid Neoplasms

Asmita Shukla, Dakshin Padmanabhan, Paul Kim, Jeff Aguilar, Sushmitha Nanja Reddy, Vikram Dhillon, David Carr, Jay Yang, Julie Boerner, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 4254.

https://doi.org/10.1182/blood-2024-212206

Published: 2024

Journal Articles

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Jeff Aguilar, Vikram Dhillon, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Julie Boerner, Gregory Dyson, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6445.

https://doi.org/10.1182/blood-2023-190854

Published: 2023

Journal Articles

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson

Blood (2023) 142 (Supplement 1): 6447.

https://doi.org/10.1182/blood-2023-189972

Published: 2023

Journal Articles

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Lakshmi Bhavani Potluri, Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Gregory Dyson, Julie Boerner, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 1853.

https://doi.org/10.1182/blood-2023-191277

Published: 2023

Journal Articles

Recurrent KMT2C Mutations As Clonal Hematopoiesis Is Common after Chemotherapy Exposure in Hodgkin's Lymphoma Patients

Sushmitha Nanja Reddy, Abdul Moiz Khan, Vikram Dhillon, Ali Al Sbihi, Amanda Tear, Breanna William, Sonubar Virk, Julie Boerner, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6584–6585.

https://doi.org/10.1182/blood-2022-170971

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Multiomics-guided ex vivo drug sensitivity testing in Relapsed/Refractory Acute Myeloid Leukemia

Targeting the compass complex to overcome resistance in KMT2A-rearranged Acute Myeloid Leukemia

Clinical implications of epigenetic age acceleration as a novel biomarker in Acute Myeloid Leukemia

Clonal Evolution of TP53 Configurations with Treatment Predict Prognosis in Myeloid Neoplasms

Racial Disparities in Clonal Hematopoiesis Among Solid Cancer Patients with Cardiovascular Diseases

Trial in Progress: Iberdomide and Daratumumab As Maintenance Therapy after an Autologous Stem Cell Transplant for Multiple Myeloma (the IBEX Trial)

Longitudinal Sequencing to Investigate Clonal Evolution in Myeloid Neoplasms

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Recurrent KMT2C Mutations As Clonal Hematopoiesis Is Common after Chemotherapy Exposure in Hodgkin's Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only